EGFR and non-small cell lung carcinoma: More importantly, we had proven that inhibition of EREG/ErbB signaling pathway played a key function in reversing resistance of NSCLC by suppressing stemness-associated genes, Nanog and Sox2, expression and inhibiting spheres forming ability, as mediated through ERK signaling (Fig. 6I).